How much does Wren Laboratories Limited make?

Wren Laboratories Limited reported revenue of £12.9m and £1.7m profit in the year to 31 Mar 2025, according to its accounts filed at Companies House.

How many employees does Wren Laboratories Limited have?

Wren Laboratories Limited reported an average of 101 employees in the year to 31 Mar 2025.

Is Wren Laboratories Limited profitable?

Yes — Wren Laboratories Limited reported a profit of £1.7m in the year to 31 Mar 2025.

Company No. 05094520 · Incorporated 5 Apr 2004

Wren Laboratories Limited

Registered name: WREN LABORATORIES LIMITED

Part of Medipharma Group Limited group

Wren Laboratories Limited made £12.9m revenue and £1.7m profit in the year to 31 Mar 2025. read from filing text

Wren Laboratories Limited’s revenue grew 26% to £12.9m in the year to 31 Mar 2025, with £1.7m profit and 101 employees. The company is classified under “other manufacturing” and is based in Andover; we hold 4 years of its filed accounts.

Full P&L filedSection C · ManufacturingSIC 32990Other manufacturing n.e.c.

Status: Active
Location: Andover, South West
Age: 22 yrs · since 2004
Type: Private Limited Company

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently. From the filing: “Wren Laboratories Limited is controlled by Medipharma Group Ltd, a company registred in England and Wales. The results of Wren Laboratories Limited are included in the consolidated financial statement”

Latest accounts · year to 31 Mar 2025

Key figures

Capital-lightOperating leverageDoing more with less

Revenue

£12.9m

Growth ▲25.8%

Profit

£1.7m

Growth ▲592.4%

Profit margin

12.9%

Gross 52.7%

Employees

101

Change ▼1%

Profit / employee

£16.5k

Revenue/employee £128k

Profitable streak

4yrs

Consecutive profitable years in our data

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

4 filed years

Financial history

Multi-year financials, oldest to newest
Year to	31 Mar 2022	31 Mar 2023	31 Mar 2024	31 Mar 2025
Disclosure	Full P&Lread from filing text	Full P&Lread from filing text	Full P&Lread from filing text	Full P&Lread from filing text
Profit & loss
Revenue (turnover)	£11.7m	£10.7m	£10.2m	£12.9m
Cost of sales	£5.1m	£4.4m	£4.4m	£6.1m
Gross profit	£6.7m	£6.3m	£5.9m	£6.8m
Operating profit	£304k	£769k	£319k	£1.3m
Profit before tax	£304k	£773k	£321k	£2m
Profit after tax	£249k	£640k	£241k	£1.7m
Profit (best available)	£249k	£640k	£241k	£1.7m
Staff costs	£2.8m	£3.5m	£3.8m	£4m
Employees (average)	78	85	102	101
Ratios
Profit margin	2.1%	6%	2.4%	12.9%
Gross margin	56.8%	59.2%	57.5%	52.7%
Revenue per employee	£150k	£126k	£100k	£128k
Profit per employee	£3.2k	£7.5k	£2.4k	£16.5k
Growth (year on year)
Revenue growth	—	▼8.7%	▼4.3%	▲25.8%
Profit growth	—	▲157.5%	▼62.4%	▲592.4%
Headcount growth	—	▲9%	▲20%	▼1%
Balance sheet — indirect signals, not revenue
Cash at bank	£1.6m	£491k	£753k	£1.1m
Net assets	£2.6m	£3.2m	£1.2m	£1.4m
Fixed assets	£120k	£142k	£164k	£1.1m
Current assets	£4.8m	£5.1m	£5.3m	£6.5m
Debtors	£855k	£1m	£1.5m	£2m
Deferred income	£686k	£426k	£487k	£809k
Source	FullAccounts · bulk data Dec 2023	FullAccounts · bulk data Dec 2023	FullAccounts · bulk data Oct 2024	FullAccounts · bulk data Dec 2025

Derived from the latest filing

How the business works

Profit margin: 12.9%; Profit ÷ revenue.
Gross margin: 52.7%; Gross profit ÷ revenue. High for software and services.
Revenue per employee: £128k; Revenue ÷ average employees.
Profit per employee: £16.5k; Profit ÷ average employees.
Cash conversion: —; Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
Fixed assets ÷ revenue: 8.9%; Capital intensity. Low = capital-light, cheaper to start.
Deferred income ÷ revenue: 6.3%; Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
Debtors ÷ revenue: 15.6%; Money owed by customers. Low = customers pay quickly.

Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets: ▲14%; Now £1.4m
Cash at bank: ▲40%; Now £1.1m
Headcount: ▼1%; Now 101
Deferred income: ▲66%; Now £809k
Fixed assets: ▲599%; Now £1.1m

Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.

Corporate ownership

Group structure

Ownership chain

Medipharma Group Limited (registered outside the UK register)ultimate parent75–100%
Wren Laboratories Limitedthis company

Bands show the share of ownership each company holds in the one below it.

Subsidiaries (1)

Medipharma LimitedFigures not disclosed

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Companies House profile Filing history & original accounts

Latest figures from FullAccounts for the year to 31 Mar 2025 (profit £1.7m), from the Companies House accounts bulk data published Dec 2025. Spotted an error? Request a correction.

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.